Lymph node metastases in prostate cancer patients are mainly found in normal sized lymph nodes and detection is a major challenge. USPIO-enhanced MRI with ferumoxtran-10 discriminates between normal and suspicious lymph nodes. We examined 20 prostate cancer patients with high risk of advanced disease with USPIO-enhanced MRI at 3 and at 7 Tesla, and compared the amount, the level of suspicion, and the size of lymph nodes with two readers. More, but on average not larger suspicious nodes were annotated on 7T versus 3T MRI by both readers, with less interobserver variability at 7T.
This abstract and the presentation materials are available to members only; a login is required.